The video shows the principles of the PBPK model of therapeutic proteins in the Simcyp Simulator. The tutorial demonstrates how to set up a large molecule compound, what are the model options for drug distribution, elimination and target binding and what are the important physiological parameters.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/